Pharmaceutical Business review

Therakos receives CE Mark for photopheresis system

The system will be used for the treatment of immune-mediated diseases such as acute or chronic graft-versus-host disease and cutaneous T-cell lymphoma.

Therakos Cellex photopheresis system is the next generation in a product line that offers the only validated, automated and integrated systems that are CE Marked to perform extracorporeal photopheresis, according to Therakos.